Literature DB >> 10974441

Toward optimal external-beam fractionation for prostate cancer.

D J Brenner.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10974441     DOI: 10.1016/s0360-3016(00)00591-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  12 in total

Review 1.  Charged particle therapy--optimization, challenges and future directions.

Authors:  Jay S Loeffler; Marco Durante
Journal:  Nat Rev Clin Oncol       Date:  2013-05-21       Impact factor: 66.675

2.  Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.

Authors:  Joshua A Halpern; Art Sedrakyan; Wei-Chun Hsu; Jialin Mao; Timothy J Daskivich; Paul L Nguyen; Encouse B Golden; Josephine Kang; Jim C Hu
Journal:  Cancer       Date:  2016-05-25       Impact factor: 6.860

3.  Isoeffect calculations with the linear quadratic and its extensions: An examination of model-dependent estimates at doses relevant to hypofractionation.

Authors:  Frederick W McKenna; Salahuddin Ahmad
Journal:  J Med Phys       Date:  2011-04

4.  Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects.

Authors:  D P Dearnaley; E Hall; D Lawrence; R A Huddart; R Eeles; C M Nutting; J Gadd; A Warrington; M Bidmead; A Horwich
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

5.  Prostate cancer as a first and second cancer: effect of family history.

Authors:  H Zhang; J L Bermejo; J Sundquist; K Hemminki
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

6.  Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost-IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate.

Authors:  A Bansal; R Kapoor; S K Singh; N Kumar; A S Oinam; S C Sharma
Journal:  Indian J Urol       Date:  2012-07

7.  Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis.

Authors:  Tobias Engel Ayer Botrel; Otávio Clark; Antônio Carlos Lima Pompeo; Francisco Flávio Horta Bretas; Marcus Vinicius Sadi; Ubirajara Ferreira; Rodolfo Borges Dos Reis
Journal:  Core Evid       Date:  2013-03-07

8.  Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression.

Authors:  Whoon Jong Kil; Romaine C Nichols; Bradford S Hoppe; Christopher G Morris; Robert B Marcus; William Mendenhall; Nancy P Mendenhall; Zuofeng Li; Joseph A Costa; Christopher R Williams; Randal H Henderson
Journal:  Acta Oncol       Date:  2013-04       Impact factor: 4.089

Review 9.  Locally advanced prostate cancer.

Authors:  E A Klein; P A Kupelian; R Dreicer; D Peereboom; C Zippe
Journal:  Curr Treat Options Oncol       Date:  2001-10

10.  Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer.

Authors:  Jasper Yuen; George Rodrigues; Kristina Trenka; Terry Coad; Slav Yartsev; David D'Souza; Michael Lock; Glenn Bauman
Journal:  Radiat Oncol       Date:  2008-01-07       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.